Inventor · San Juan Bautista, CA, US

Gerard Zurawski

50Patents
14h-index
33Co-inventors
84Inventor score

Filing activity: Sep 4, 1986 → Jun 6, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US5596072A Method of refolding human IL-13 Emerging Cross-Sectional Technologies 51 Expired
US5696234A Muteins of mammalian cytokine interleukin-13 Human Necessities 42 Expired
US7786267B2 Multivariable antigens complexed with targeting humanized monoclonal antibody Chemistry; Metallurgy 42 Active
US8518410B2 Fusion protein with HIV antigen Emerging Cross-Sectional Technologies 40 Active
US9102734B2 Fusion proteins comprising antibody and HPV E6 and E7 antigens Emerging Cross-Sectional Technologies 39 Active
US8961991B2 Anti-CD40 targeted fusion proteins Emerging Cross-Sectional Technologies 38 Active
US8449888B2 Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells Chemistry; Metallurgy 34 Active
US8236934B2 Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR) Chemistry; Metallurgy 32 Active
US5001230A T cell activation markers Chemistry; Metallurgy 31 Expired
US8728481B2 Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR) Chemistry; Metallurgy 30 Active
US9102730B2 Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells Chemistry; Metallurgy 25 Active
US8586052B2 Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells Chemistry; Metallurgy 25 Active
US9416186B2 Antigen presenting cell targeted anti-viral vaccines Emerging Cross-Sectional Technologies 25 Active
US9234040B2 Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells Chemistry; Metallurgy 25 Active
US9109011B2 Dendritic cell-specific antibody conjugate comprising anti-CD40 monoclonal antibodies conjugated to HIV-1 Gag/Nef Chemistry; Metallurgy 13 Active
US6479638B1 Antibodies that specifically bind DNAX leukocyte associated immunoglobulin-like receptor Chemistry; Metallurgy 10 Expired
US5017692A Truncated human interleukin-a alpha Chemistry; Metallurgy 10 Expired
US8481314B2 Activation of human antigen-presenting cells through dendritic cell lectin-like oxidized LDL receptor-1 (LOX-1) Emerging Cross-Sectional Technologies 9 Active
US9339556B2 Activation of human antigen-presenting cells through dendritic cell lectin-like oxidized LDL receptor-1 (LOX-1) Emerging Cross-Sectional Technologies 9 Active
US6140098A Nucleic acids encoding mammalian proteinases; related reagents Emerging Cross-Sectional Technologies 8 Expired
US9562104B2 Anti-CD40 antibodies Emerging Cross-Sectional Technologies 5 Active
US9315580B2 Vaccines directed to langerhans cells Chemistry; Metallurgy 5 Active
US7005501B2 Purified mammalian cytokines; related reagents and methods Human Necessities 4 Expired
US7655761B2 IL-17-like cytokine binding compounds and antibodies Human Necessities 3 Active
US7999078B2 Antibodies that bind DNAX leukocyte associated immunoglobulin-like receptor Emerging Cross-Sectional Technologies 2 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.